Serum High Sensitive - C Reactive Protein Levels in Type 2 Diabetes Mellitus -A Case Control Study
Sangappa Virupaxappa Kashinakunti, Manjula Rangappa, Gurupadappa Shantappa Kallaganada
Abstract
Open-access reader
Sangappa Virupaxappa Kashinakunti, Manjula Rangappa, Gurupadappa Shantappa Kallaganada
Abstract
Open-access reader
Background: The process of inflammation induces hepatic synthesis of various acute phase proteins such as high sensitivity C-reactive protein (hs-CRP) which is believed to play a role in insulin resistance.Higher incidence of type-2 diabetes mellitus has been observed with high levels of hs-CRP.Objectives: The present case control study was under taken to 1. Find the serum hs-CRP levels in type 2 DM patients, 2. Find the serum hs-CRP levels in healthy controls, 3. Compare hs-CRP level Original Research Articlebetween type 2 DM patients and healthy control subjects, 4. Find correlation between HbA1c and hs-CRP in type 2 DM patients and 5. Find the optimum cut-off value for hs-CRP for type 2 DM Materials and Methods: The study was conducted on type 2 DM subjects from Jan 2015 to February 2016.The FBS, PPBS, HbA1c and hs-CRP was estimated.SPSS software was used for statistical analysis.Pearson's correlation coefficient was used to show the correlation.Results: The biochemical parameters FBS, PPBS, HbA1c and hs-CRP levels were increased in cases compared to controls.The p value was 0.0001 for all the parameters, which is highly significant.There is a positive correlation between the HbA1c and hs-CRP.The area under the ROC curve for serum hs-CRP values at various cut-off was 0.797 and the best cut-off of serum hs-CRP levels greater than 3.86 mg/L.Conclusion: The hs-CRP was higher in healthy controls of this ethnic group.hs-CRP levels were high in type 2 diabetes mellitus, which correlated with HbA1c.Routine screening for hs-CRP in diabetes patients can be done with best cut-off value of 3.86 mg/L.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: The process of inflammation induces hepatic synthesis of various acute phase proteins such as high sensitivity C-reactive protein (hs-CRP) which is believed to play a role in insulin resistance.Higher incidence of type-2 diabetes mellitus has been observed with high levels of hs-CRP.Objectives: The present case control study was under taken to 1. Find the serum hs-CRP levels in type 2 DM patients, 2. Find the serum hs-CRP levels in healthy controls, 3. Compare hs-CRP level Original Research Articlebetween type 2 DM patients and healthy control subjects, 4. Find correlation between HbA1c and hs-CRP in type 2 DM patients and 5. Find the optimum cut-off value for hs-CRP for type 2 DM Materials and Methods: The study was conducted on type 2 DM subjects from Jan 2015 to February 2016.The FBS, PPBS, HbA1c and hs-CRP was estimated.SPSS software was used for statistical analysis.Pearson's correlation coefficient was used to show the correlation.Results: The biochemical parameters FBS, PPBS, HbA1c and hs-CRP levels were increased in cases compared to controls.The p value was 0.0001 for all the parameters, which is highly significant.There is a positive correlation between the HbA1c and hs-CRP.The area under the ROC curve for serum hs-CRP values at various cut-off was 0.797 and the best cut-off of serum hs-CRP levels greater than 3.86 mg/L.Conclusion: The hs-CRP was higher in healthy controls of this ethnic group.hs-CRP levels were high in type 2 diabetes mellitus, which correlated with HbA1c.Routine screening for hs-CRP in diabetes patients can be done with best cut-off value of 3.86 mg/L.
Key concepts: C-reactive protein, Internal medicine, Acute-phase protein, Insulin resistance, Type 2 Diabetes Mellitus, Endocrinology, Inflammation, Medicine